期刊文献+

孕激素受体蛋白表达在脑膜瘤复发中相关性分析

原文传递
导出
摘要 目的:通过对脑膜瘤术后复发组与术后未复发组的孕激素受体蛋白表达的检测,探讨其在脑膜瘤术后复发中表达的意义。方法:通过对术后证实为脑膜瘤的38例患者进行回访,择出未见复发组32例,复发组6例,对其病理组织采用免疫组化S-P法进行PR的测定,观察PR在不同组别中的表达差异。结果:复发组PR阳性表达率是16.67%(1/6),未复发组是68.75%(22/32),未复发组PR阳性率高于复发组,两组之间有明显的差异(P<0.05)。结论:孕激素受体蛋白阳性表达率可作为预测脑膜瘤术后是否复发的参考因素。
出处 《中国误诊学杂志》 CAS 2009年第3期550-551,共2页 Chinese Journal of Misdiagnostics
  • 相关文献

参考文献3

二级参考文献45

  • 1Cadepond F, Ulmann A, Baulieu EE. RU486 (MIFEPRISTONE) :Mechanisms of action and clinical uses. Annual Review of Medicine,1997, 48:129-156.
  • 2Koide. Mifepristone auxiliary therapeutic use in cancer and related disorders. J Reprod Med, 1998,43 : 551-560.
  • 3Chamberlain MC. Intracerebral meningiomas. Curr Treat Options Neurol, 2004,6 : 297-305.
  • 4Matsuda Y, Kawamoto K, Kiya K, et al. Antitumor effects of antiprogesterone on human meningioma cells in vitro and in vivo. J Neurosurg, 1994, 80:527-534.
  • 5Takeuchi H, Kubota T, Kabuto M, et al. Prediction of recurrence in histologically benign meningiomas: proliferating cell nuclear antigen and Ki-67 immunohistochemical study. Surg Neurol, 1997,48:501-506.
  • 6Kvasha MS, Zakhartsev LM. Estrogen and progesterone receptors in cerebral meningioma and their clinical value. Klin Khir,2002:50-52.
  • 7Wahab M, Al-Azzawi F. Meningioma and hormonal influences.Climacteric, 2003, 6: 285-292.
  • 8Verheijen FM, Sprong M, Jacobs HM, et al. Progesterone receptor isoform expression in human meningiomas. Eur J Cancer, 2001,37 :1488-1495.
  • 9Wolfsberger S, Doostkam S, Boecher-Schwarz HG, et al.Progesterone-receptor index in meningiomas: correlation with clinicopathological parameters and review of the literature. Neurosurg Rev,2004,27 : 238-245.
  • 10Strik HM, Strobelt I, Pietsch-Breitfeld B, et al. The impact of progesterone receptor expression on relapse in the long-term clinical course of 93 benign meningiomas. In Vivo, 2002,16: 265-270.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部